Patent Applications published on May 6, 2021 - page 4

#901 ✅ Patent 11,771,638 granted on 2023-10-03
US20210128440A1
Human necessities

Stable vitamin C compositions

#902
US20210128441A1
Human necessities

COMPOSITIONS AND METHODS FOR CURLY HAIR

#903
US20210128442A1
Human necessities

ORGANIC COMPOUNDS

#904 ✅ Patent 11,590,068 granted on 2023-02-28
US20210128443A1
Human necessities

Personal care products

#905 ✅ Patent 11,266,589 granted on 2022-03-08
US20210128444A1
Human necessities

Hair dyeing composition comprising an oxidation dye, a scleroglucan gum, and an alkylpolyglycoside

#906 ✅ Patent 11,696,886 granted on 2023-07-11
US20210128445A1
Human necessities

Cosmetic

#907
US20210128446A1
Human necessities

COSMETIC COMPOSITION COMPRISING BIODEGRADABLE POLYMERS

#908 ✅ Patent 11,969,495 granted on 2024-04-30
US20210128447A1
Human necessities

Sulphate-free and nonionic surfactant-free cleansing composition

#909 ✅ Patent 11,602,499 granted on 2023-03-14
US20210128448A1
Human necessities

Composition for keratin fibers

#910 ✅ Patent 11,964,044 granted on 2024-04-23
US20210128449A1
Human necessities

Phase change cosmetic composition

#911 ✅ Patent 11,446,232 granted on 2022-09-20
US20210128450A1
Human necessities

Natural skin penetrating moisturizer formulations

#912 ✅ Patent 11,260,021 granted on 2022-03-01
US20210128451A1
Human necessities

Cosmetic complex for bioactive hydration, cosmetic composition, use and method

#913
US20210128452A1
Human necessities

COMPOSITIONS AND METHODS OF IMPROVING THE SKIN MICROBIOME

#914
US20210128453A1
Human necessities

CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE

#915
US20210128454A1
Human necessities

ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN

#916
US20210128455A1
Human necessities

Drug Delivery Systems

#917 ✅ Patent 11,464,733 granted on 2022-10-11
US20210128456A1
Human necessities

Enema for rectal application

#918
US20210128457A1
Human necessities

METHOD OF DELIVERING DRUGS TO INNER EAR FACILITATED BY MICROBUBBLES

#919 ✅ Patent 12,186,295 granted on 2025-01-07
US20210128458A1
Human necessities

Ophthalmic compositions containing a nitric oxide releasing prostamide

#920
US20210128459A1
Human necessities

GUMMY COMPOSITIONS FOR NUTRITIONAL SUPPLEMENTATION

#921 ✅ Patent 11,389,399 granted on 2022-07-19
US20210128460A1
Human necessities

Residence structures and related methods

#922
US20210128461A1
Human necessities

Method of Delivering Amphiphilic Bioactive Substances Targeting the Respiratory Tract

#923 ✅ Patent 11,844,859 granted on 2023-12-19
US20210128462A1
Human necessities

Dry powder compositions for intranasal delivery

#924
US20210128463A1
Human necessities

Two Stage Microchip Drug Delivery Device and Methods

#925 ✅ Patent 11,872,310 granted on 2024-01-16
US20210128464A1
Human necessities

Preparation for oral cavity

#926 ✅ Patent 11,883,531 granted on 2024-01-30
US20210128465A1
Human necessities

Pharmaceutical compositions of IL-2

#927
US20210128466A1
Human necessities

REDUCED VOLUME FORMULATIONS INCLUDING AMINO ACID ENTITIES

#928 ✅ Patent 12,296,046 granted on 2025-05-13
US20210128467A1
Human necessities

Micro-emulsion containing creatine fatty-ester, method for preparing said micro-emulsion and uses thereof

#929 ✅ Patent 11,730,699 granted on 2023-08-22
US20210128468A1
Human necessities

Lipid-based ophthalmic emulsion

#930 ✅ Patent 12,048,766 granted on 2024-07-30
US20210128469A1
Human necessities

Gamma polyglutamated tetrahydrofolates and uses thereof

#931 ✅ Patent 11,896,712 granted on 2024-02-13
US20210128470A1
Human necessities

Method for treating a metabolite toxicopathy

#932 ✅ Patent 12,220,482 granted on 2025-02-11
US20210128471A1
Human necessities

Liposome composition and method for producing the same

#933
US20210128472A1
Human necessities

EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE

#934
US20210128473A1
Human necessities

LIPID DEPOT FORMULATIONS

#935
US20210128474A1
Human necessities

METHODS FOR MANUFACTURING A LIPOSOME ENCAPSULATED RNA

#936 ✅ Patent 11,938,220 granted on 2024-03-26
US20210128475A1
Human necessities

Sustained-release anesthetic compositions and methods of preparation thereof

#937 ✅ Patent 12,226,530 granted on 2025-02-18
US20210128476A1
Human necessities

Lenalidomide gastro-retentive sustained-release tablet and preparation method thereof

#938 ✅ Patent 11,337,927 granted on 2022-05-24
US20210128477A1
Human necessities

Sustained-release dosage forms of ruxolitinib

#939 ✅ Patent 11,413,250 granted on 2022-08-16
US20210128478A1
Human necessities

Shape changing drug delivery devices and methods

#940 ✅ Patent 12,102,721 granted on 2024-10-01
US20210128479A1
Human necessities

Dosage forms of controlled release at specific gastrointestinal sites

#941 ✅ Patent 11,357,733 granted on 2022-06-14
US20210128480A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#942 ✅ Patent 11,523,991 granted on 2022-12-13
US20210128481A1
Human necessities

Plant soft capsule and preparation method and application thereof

#943
US20210128482A1
Human necessities

CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY

#944 ✅ Patent 11,642,317 granted on 2023-05-09
US20210128483A1
Human necessities

Nanocrystals, compositions, and methods that aid particle transport in mucus

#945
US20210128484A1
Human necessities

MICROSPHERES FOR EXTENDED, CONTROLLED RELEASE OF THERAPEUTIC AGENTS

#946
US20210128485A1
Human necessities

NANOPARTICLES FOR GENE EXPRESSION AND USES THEREOF

#947
US20210128486A1
Human necessities

NANOPARTICLE STRUCTURE

#948 ✅ Patent 11,648,208 granted on 2023-05-16
US20210128487A1
Human necessities

Nano complex comprising a nano drug delivery matrix; and a extract or a ginsenoside isolated therefrom

#949 ✅ Patent 11,639,329 granted on 2023-05-02
US20210128488A1
Human necessities

Lipids for use in lipid nanoparticle formulations

#950 ✅ Patent 11,504,338 granted on 2022-11-22
US20210128489A1
Human necessities

GM3 functionalized nanoparticles

#951 ✅ Patent 12,144,899 granted on 2024-11-19
US20210128490A1
Human necessities

Tetrabenazine transdermal delivery device

#952 ✅ Patent 11,318,108 granted on 2022-05-03
US20210128491A1
Human necessities

Use of carotenoid derivatives to reduce the toxicity and increase the efficacy of anti-EGFR antitumor treatments

#953
US20210128492A1
Human necessities

COMPOSITION FOR PREVENTING AND/OR IMPROVING BRAIN DYSFUNCTION COMPRISING A LUTEIN OR SALT THEREOF AND A PLANT PRODUCT OF THE GENUS TRAPA

#954
US20210128493A1
Human necessities

Pet Food Supplement

#955
US20210128494A1
Human necessities

TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS WITH REDOX-ACTIVE THERAPEUTICS

#956
US20210128495A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING FATIGUE ASSOCIATED WITH DISORDERED SLEEP USING VERY LOW DOSE CYCLOBENZAPRINE

#957
US20210128496A1
Human necessities

DROPROPIZINE IN COMBINATION WITH AMBROXOL IN THE DOSAGE FORM OF SYRUP OR TABLETS

#958 ✅ Patent 11,911,352 granted on 2024-02-27
US20210128497A1
Human necessities

Compositions, methods and devices for forming implants from injected liquids

#959 ✅ Patent 11,424,006 granted on 2022-08-23
US20210128498A1
Human necessities

Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide

#960 ✅ Patent 11,382,880 granted on 2022-07-12
US20210128499A1
Human necessities

Method for improving digestive health

#961
US20210128500A1
Human necessities

Methods of Treating Conditions Associated with Leaky Gut Barrier

#962 ✅ Patent 11,701,333 granted on 2023-07-18
US20210128501A1
Human necessities

Antibacterial compounds

#963
US20210128502A1
Human necessities

METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS

#964 ✅ Patent 11,166,927 granted on 2021-11-09
US20210128503A1
Human necessities

Autoimmune disorder treatment using RXR agonists

#965 ✅ Patent 11,246,845 granted on 2022-02-15
US20210128504A1
Human necessities

Autoimmune disorder treatment using RXR agonists

#966 ✅ Patent 11,103,472 granted on 2021-08-31
US20210128505A1
Human necessities

Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)

#967 ✅ Patent 11,752,120 granted on 2023-09-12
US20210128506A1
Human necessities

Use of succinic acid in increasing sensitivity of bacteria to antibiotics

#968
US20210128507A1
Human necessities

FORMULATION FOR USE IN A METHOD OF TREATMENT OF PAIN

#969 ✅ Patent 11,633,372 granted on 2023-04-25
US20210128508A1
Human necessities

Compositions and methods for treating autism

#970
US20210128509A1
Human necessities

USE OF MAGNETIC RESONANCE SPECTROSCOPY TO CALIBRATE AND SELECT DOSES, FORMULATIONS, AND DEVICES FOR INTRA-NASAL ADMINISTRATION OF N-ACETYLCYSTEINE

#971
US20210128510A1
Human necessities

SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID

#972
US20210128511A1
Human necessities

PRODRUG COMPOSITIONS AND METHODS OF TREATMENT

#973
US20210128512A1
Human necessities

USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES

#974 ✅ Patent 12,115,146 granted on 2024-10-15
US20210128513A1
Human necessities

Treatment of skeletal-related events for breast cancer patients

#975
US20210128514A1
Human necessities

METHOD AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF BROAD SPECTRUM VIRUS AILMENTS COMPRISING A CALCIUM CHANNEL BLOCKER OR A CALMODULIN BLOCKER

#976
US20210128515A1
Human necessities

FORMULATION OR REMEDY AGAINST ANDROGENETIC ALOPECIA

#977
US20210128516A1
Human necessities

CYCLODEXTRIN-BASED POLYMERS FOR DELIVERING THE THERAPEUTIC AGENTS COVALENTLY BOUND THERETO

#978
US20210128517A1
Human necessities

TREATMENT OF CIRCADIAN RHYTHM DISORDERS

#979
US20210128518A1
Human necessities

CANNABINOID-CONTAINING DERMATOLOGICAL COMPOSITIONS AND METHODS USING SAME

#980 ✅ Patent 12,016,838 granted on 2024-06-25
US20210128519A1
Human necessities

Stabilized protein-bound cannabinoid compositions

#981
US20210128520A1
Human necessities

NEUROPROTECTIVE ISOFLAVONE COMPOSITIONS AND METHODS

#982
US20210128521A1
Human necessities

METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE APPLICATIONS

#983
US20210128522A1
Human necessities

TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATMENT OF MALE SUBJECTS

#984 ✅ Patent 12,156,862 granted on 2024-12-03
US20210128523A1
Human necessities

Medicaments for the treatment of vasoconstriction related diseases or disorders

#985
US20210128524A1
Human necessities

TANNIN AND ANTI-GLIADIN ANTIBODY COMPOSITIONS FOR TREATMENT OF A DISEASE OF THE INTESTINAL TRACT

#986 ✅ Patent 11,147,794 granted on 2021-10-19
US20210128525A1
Human necessities

Treatment for primary biliary cholangitis

#987
US20210128526A1
Human necessities

EYE DROPS TO TREAT CHEMICALLY INDUCED CORNEAL DAMAGE

#988
US20210128527A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING HEMORRHAGIC STROKE

#989
US20210128528A1
Human necessities

USE OF 5HT2A INVERSE AGONISTS FOR TREATING PSYCHOSIS

#990
US20210128529A1
Human necessities

DRUG CONTAINING PYRAZOLONE DERIVATIVE

#991 ✅ Patent 11,285,133 granted on 2022-03-29
US20210128530A1
Human necessities

2- or 3-imidazolines as carbapenemases inhibitors

#992
US20210128531A1
Human necessities

STABLE COMPOSITION INCLUDING ANGIOTENSIN II, PREPARATION METHOD AND APPLICATION METHOD THEREOF

#993 ✅ Patent 11,806,335 granted on 2023-11-07
US20210128532A1
Human necessities

Heterocyclic carboxylate compounds as glycolate oxidase inhibitors

#994 ✅ Patent 11,464,763 granted on 2022-10-11
US20210128533A1
Human necessities

Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof

#995
US20210128534A1
Human necessities

DRUG DELIVERY SYSTEMS

#996 ✅ Patent 11,547,703 granted on 2023-01-10
US20210128535A1
Human necessities

Substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereof

#997
US20210128536A1
Human necessities

WEAKLY BASIC DRUG AND IONIC POLYMER PHARMACEUTICAL FORMULATIONS AND METHODS OF FORMATION AND ADMINISTRATION THEREOF

#998
US20210128537A1
Human necessities

T-TYPE CALCIUM CHANNEL MODULATORS AND METHODS OF USE THEREOF

#999 ✅ Patent 11,633,385 granted on 2023-04-25
US20210128538A1
Human necessities

Combination compositions for treatment of cancer

#1000
US20210128539A1
Human necessities

SUSTAINED RELEASE PYRIDOSTIGMINE COMPOSITIONS

#1001 ✅ Patent 11,690,834 granted on 2023-07-04
US20210128540A1
Human necessities

Composition, uses, and methods of treating spinal disc degeneration through sonic hedgehog signaling pathway

#1002 ✅ Patent 11,723,898 granted on 2023-08-15
US20210128541A1
Human necessities

Androgen receptor inhibitors for the treatment of non-metastatic castration-resistant prostate cancer in subjects with severe hepatic impairment

#1003 ✅ Patent 12,005,053 granted on 2024-06-11
US20210128542A1
Human necessities

Veterinary pharmaceutical compositions for direct systemic introduction

#1004 ✅ Patent 11,730,724 granted on 2023-08-22
US20210128543A1
Human necessities

Methods of treatment

#1005
US20210128544A1
Human necessities

OPHTHALMIC COMPOSITIONS COMPRISING BILASTINE, A BETA-CYCLODEXTRIN AND AT LEAST ONE GELLING AGENT

#1006 ✅ Patent 12,090,147 granted on 2024-09-17
US20210128545A1
Human necessities

Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

#1007 ✅ Patent 11,642,338 granted on 2023-05-09
US20210128546A1
Human necessities

Atropine pharmaceutical compositions

#1008
US20210128547A1
Human necessities

AGGRESSIVE LIPID LOWERING THERAPY IN CORONARY ARTERY DISEASE

#1009
US20210128548A1
Human necessities

EXTERNAL PREPARATION COMPRISING PYRIDONECARBOXYLIC ACID DERIVATIVE

#1010
US20210128549A1
Human necessities

OXYCODONE AND METHYLNALTREXONE MULTIPARTICULATES AND SUSPENSIONS CONTAINING THEM

#1011 ✅ Patent 11,744,830 granted on 2023-09-05
US20210128550A1
Human necessities

Ameliorative agent for cytokine release syndrome and so on

#1012 ✅ Patent 11,833,147 granted on 2023-12-05
US20210128551A1
Human necessities

Procaspase 3 activation by combination therapy

#1013
US20210128552A1
Human necessities

IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#1014
US20210128553A1
Human necessities

COMBINATION COMPOSITIONS FOR IMMUNOTHERAPY

#1015
US20210128554A1
Human necessities

ANTI-FLAVIVIRIDAE ACTIVITY OF ANTI-RETROVIRAL NON-NUCLEOSIDE (NNRTIS) AND NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIS)

#1016 ✅ Patent 11,351,170 granted on 2022-06-07
US20210128555A1
Human necessities

Substituted pyrimidines as CDK4/6 inhibitors

#1017 ✅ Patent 11,590,134 granted on 2023-02-28
US20210128556A1
Human necessities

Aminopyrimidine amide autophagy inhibitors and methods of use thereof

#1018 ✅ Patent 11,844,800 granted on 2023-12-19
US20210128557A1
Human necessities

Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia

#1019 ✅ Patent 11,534,442 granted on 2022-12-27
US20210128558A1
Human necessities

Treatment of adipocytes

#1020 ✅ Patent 11,534,443 granted on 2022-12-27
US20210128559A1
Human necessities

Quinazoline compounds, preparation method, use, and pharmaceutical composition thereof

#1021 ✅ Patent 11,208,413 granted on 2021-12-28
US20210128560A1
Human necessities

Pyrimidopyrimidinones useful as wee-1 kinase inhibitors

#1022
US20210128561A1
Human necessities

MRGX Receptor Antagonists

#1023
US20210128562A1
Human necessities

INTRAVENOUS INFUSION DOSAGE FORM

#1024 ✅ Patent 11,491,158 granted on 2022-11-08
US20210128563A1
Human necessities

N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors

#1025 ✅ Patent 11,701,362 granted on 2023-07-18
US20210128564A1
Human necessities

Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1- methylcyclohexane-1-carboxamide

#1026 ✅ Patent 11,590,139 granted on 2023-02-28
US20210128565A1
Human necessities

Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

#1027
US20210128566A1
Human necessities

NOVEL FUNCTIONALIZED PURINE-2,6-DIONES AND THEIR USE IN MEDICINE

#1028
US20210128567A1
Human necessities

Compositions and Methods for Cognitive, Immune and Digestive Support in Patients with Autism Spectrum Disorder

#1029 ✅ Patent 11,452,726 granted on 2022-09-27
US20210128568A1
Human necessities

Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same

#1030
US20210128569A1
Human necessities

ORODISPERSIBLE FORMULATION OF VARDENAFIL

#1031
US20210128570A1
Human necessities

METHODS FOR TREATING PULMONARY FIBROSIS

#1032 ✅ Patent 11,077,113 granted on 2021-08-03
US20210128571A1
Human necessities

6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes

#1033 ✅ Patent 11,660,301 granted on 2023-05-30
US20210128572A1
Human necessities

Combination of ATR kinase inhibitors with PARP inhibitors

#1034 ✅ Patent 11,285,159 granted on 2022-03-29
US20210128573A1
Human necessities

Dosing regimens for use in treating myelofibrosis and MPN-related disorders with navitoclax

#1035
US20210128574A1
Human necessities

NOVEL USES

#1036 ✅ Patent 11,207,327 granted on 2021-12-28
US20210128575A1
Human necessities

Pharmaceutical compositions comprising meloxicam

#1037 ✅ Patent 11,077,117 granted on 2021-08-03
US20210128576A1
Human necessities

Pharmaceutical compositions comprising meloxicam

#1038 ✅ Patent 11,351,178 granted on 2022-06-07
US20210128577A1
Human necessities

Selective HDAC6 inhibitors

#1039
US20210128578A1
Human necessities

CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE

#1040 ✅ Patent 11,969,431 granted on 2024-04-30
US20210128579A1
Human necessities

Formulations for treatment of post-traumatic stress disorder

#1041 ✅ Patent 11,426,415 granted on 2022-08-30
US20210128580A1
Human necessities

Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders

#1042 ✅ Patent 11,241,442 granted on 2022-02-08
US20210128581A1
Human necessities

Methods of use for TRP channel antagonist-based combination cancer therapies

#1043 ✅ Patent 11,141,399 granted on 2021-10-12
US20210128582A1
Human necessities

Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis

#1044
US20210128583A1
Human necessities

INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES

#1045
US20210128584A1
Human necessities

USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

#1046 ✅ Patent 10,987,364 granted on 2021-04-27
US20210128585A1
Human necessities

Synthetic progestogens and pharmaceutical compositions comprising the same

#1047
US20210128586A1
Human necessities

METHODS OF SIZING 6B,7B:15B,16B-DIMETHYLENE-3-OXO-17A-PREGN-4-ENE-21,17-CARBOLACTONE PARTICLES AND COMPOSITIONS COMPRISING THE SAME

#1048
US20210128587A1
Human necessities

OMEGA-3 FATTY ACID AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS

#1049
US20210128588A1
Human necessities

PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID

#1050 ✅ Patent 11,701,370 granted on 2023-07-18
US20210128589A1
Human necessities

Phosphonium ion channel blockers and methods for use

#1051 ✅ Patent 11,311,560 granted on 2022-04-26
US20210128590A1
Human necessities

Cyclic plasmenylethanolamines

#1052
US20210128591A1
Human necessities

IONIC POLYMERS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS

#1053 ✅ Patent 12,285,437 granted on 2025-04-29
US20210128592A1
Human necessities

Reversing the undesirable pH-profile of doxorubicin via activation of a disubstituted maleamic acid prodrug at tumor acidity

#1054 ✅ Patent 11,285,167 granted on 2022-03-29
US20210128593A1
Human necessities

Synergistic nutritional neuroprotective compositions for ameliorating neural dysfunction

#1055 ✅ Patent 11,413,299 granted on 2022-08-16
US20210128594A1
Human necessities

Compositions and methods for treatment of inflammatory disorders

#1056 ✅ Patent 11,219,630 granted on 2022-01-11
US20210128595A1
Human necessities

Methods and compositions relating to the treatment of fibrosis

#1057
US20210128596A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SEPTIC CARDIOMYOPATHY

#1058 ✅ Patent 11,318,155 granted on 2022-05-03
US20210128597A1
Human necessities

Hsp90 activator Aha1 drives production of pathological tau aggregates

#1059
US20210128598A1
Human necessities

Radiation-Sterilized Biodegradable Drug Delivery Compositions

#1060 ✅ Patent 11,813,277 granted on 2023-11-14
US20210128599A1
Human necessities

Methods and agents for modulating inflammation

#1061 ✅ Patent 11,992,500 granted on 2024-05-28
US20210128600A1
Human necessities

Use of methylation inhibitors for the treatment of autoimmune diseases

#1062
US20210128601A1
Human necessities

THERAPEUTIC AGENT FOR DRY EYE CHARACTERIZED BY BEING APPLIED TO EYE OF DRY EYE PATIENT WEARING SOFT CONTACT LENS

#1063 ✅ Patent 11,266,677 granted on 2022-03-08
US20210128602A1
Human necessities

Methods for treatment or prevention of leukemia

#1064 ✅ Patent 11,559,544 granted on 2023-01-24
US20210128603A1
Human necessities

Combination of a MAPK/ERK pathway inhibitor and a glycosaminoglycan for the treatment of cancer

#1065
US20210128604A1
Human necessities

Stabilized Glycosaminoglycan Preparations and Related Methods

#1066
US20210128605A1
Human necessities

COMPOSITION FOR PROMOTING SECRETORY IGA SECRETION

#1067
US20210128606A1
Human necessities

SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES

#1068
US20210128607A1
Human necessities

POLYMER-CONJUGATED METAP2 INHIBITORS, AND THERAPEUTIC METHODS OF USE THEREOF

#1069 ✅ Patent 11,013,761 granted on 2021-05-25
US20210128608A1
Human necessities

Pharmaceutical compositions

#1070
US20210128609A1
Human necessities

ONCOLOGY TREATMENTS USING ZINC AGENTS

#1071 ✅ Patent 11,813,289 granted on 2023-11-14
US20210128610A1
Human necessities

Encapsulated antimicrobials and related methods of treatment

#1072
US20210128611A1
Human necessities

AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS

#1073 ✅ Patent 12,234,480 granted on 2025-02-25
US20210128612A1
Human necessities

Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells

#1074 ✅ Patent 11,903,968 granted on 2024-02-20
US20210128613A1
Human necessities

Engineered immune cells resistant to tumor microenvironment

#1075 ✅ Patent 11,951,128 granted on 2024-04-09
US20210128614A1
Human necessities

Compositions and methods for the isolation and/or generation of specific CD4+ and CD8+ T-cell subsets

#1076 ✅ Patent 12,023,353 granted on 2024-07-02
US20210128615A1
Human necessities

Methods and compounds for improved immune cell therapy

#1077 ✅ Patent 12,161,670 granted on 2024-12-10
US20210128616A1
Human necessities

Phenotypic markers for cell therapy and related methods

#1078
US20210128617A1
Human necessities

SYNTHETIC CARS TO TREAT IL13R-alpha-2 POSITIVE HUMAN AND CANINE TUMORS

#1079
US20210128618A1
Human necessities

BCMA-TARGETED CAR-T CELL THERAPY OF MULTIPLE MYELOMA

#1080
US20210128619A1
Human necessities

USES OF ANTI-BCMA CHIMERIC ANTIGEN RECEPTORS

#1081 ✅ Patent 11,007,225 granted on 2021-05-18
US20210128620A1
Human necessities

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

#1082 ✅ Patent 11,052,116 granted on 2021-07-06
US20210128621A1
Human necessities

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

#1083 ✅ Patent 11,013,770 granted on 2021-05-25
US20210128622A1
Human necessities

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

#1084
US20210128623A1
Human necessities

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

#1085 ✅ Patent 11,040,070 granted on 2021-06-22
US20210128624A1
Human necessities

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

#1086 ✅ Patent 12,226,434 granted on 2025-02-18
US20210128625A1
Human necessities

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

#1087 ✅ Patent 11,951,134 granted on 2024-04-09
US20210128626A1
Human necessities

Cationic platelet lysate compositions and related methods

#1088
US20210128627A1
Human necessities

METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

#1089 ✅ Patent 11,957,718 granted on 2024-04-16
US20210128628A1
Human necessities

Methods for generating multipotent stem cells from tonsillar biopsies

#1090
US20210128629A1
Human necessities

REPAIR AGENT FOR LIVING TISSUE DAMAGE AND METHOD FOR PRODUCING SAID REPAIR AGENT

#1091
US20210128630A1
Human necessities

PURIFIED MESENCHYMAL STEM CELL EXOSOMES AND USES THEREOF

#1092
US20210128631A1
Human necessities

METHODS OF TREATING AUTISM SPECTRUM DISORDERS USING HUMAN UMBILICAL CORD TISSUE-DERIVED MESENCHYMAL STROMAL CELLS

#1093 ✅ Patent 11,202,805 granted on 2021-12-21
US20210128632A1
Human necessities

Methods and compositions for purification or isolation of microvesicles and exosomes

#1094 ✅ Patent 11,918,608 granted on 2024-03-05
US20210128633A1
Human necessities

Methods of treating exercise-induced pulmonary hemorrhage

#1095
US20210128634A1
Human necessities

EXOSOMES DERIVED FROM CORTICAL BONE STEM CELLS CAN AUGMENT HEART FUNCTION AFTER CARDIAC INJURY

#1096
US20210128635A1
Human necessities

Composition for Regenerating Hepatic Tissue

#1097
US20210128636A1
Human necessities

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

#1098 ✅ Patent 11,648,281 granted on 2023-05-16
US20210128637A1
Human necessities

Methods for treating cardiac conditions

#1099
US20210128638A1
Human necessities

CELLULAR, ORGAN, AND WHOLE-BODY REJUVENATION UTILIZING CORD BLOOD PLASMA AND PTEROSTILBENE

#1100
US20210128639A1
Human necessities

CELL PREPARATION FOR TREATING BRAIN TUMOR

#1101
US20210128640A1
Human necessities

HYALURONIC ACID PRODUCTION PROMOTING AGENT

#1102
US20210128641A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SKIN AND MUCOUS MEMBRANE DISEASES

#1103 ✅ Patent 11,633,436 granted on 2023-04-25
US20210128642A1
Human necessities

Cholesterol reducing compositions and methods of use thereof

#1104
US20210128643A1
Human necessities

MICRO-ORGANISMAL PRODUCT AND METHOD FOR TREATING SICKLE CELL DISEASE

#1105 ✅ Patent 11,865,146 granted on 2024-01-09
US20210128644A1
Human necessities

Methods and materials for using biomarkers which predict susceptibility to clostridium difficile infection

#1106
US20210128645A1
Human necessities

INTESTINAL MICROBE HAVING D-PSICOSE-RESPONSIVE PROLIFERATION

#1107 ✅ Patent 11,103,543 granted on 2021-08-31
US20210128646A1
Human necessities

Composition for recovering from fatigue and/or preventing fatigue accumulation

#1108
US20210128647A1
Human necessities

SPORE-BASED PROBIOTIC SUPPLEMENTATION IN DOGS AND CONTROL OF ENDOTOXEMIA

#1109 ✅ Patent 11,813,297 granted on 2023-11-14
US20210128648A1
Human necessities

Probiotic strain and its uses

#1110
US20210128649A1
Human necessities

COMPOSITION FOR PROMOTING GLUCOLIPID METABOLISM, AND PREPARATION AND APPLICATION THEREOF

#1111 ✅ Patent 11,857,581 granted on 2024-01-02
US20210128650A1
Human necessities

Antiviral methods and compositions comprising probiotic bacterial molecules

#1112
US20210128651A1
Human necessities

SURFACE FUNCTIONALIZATION OF PROBIOTICS AND APPLICATIONS THEREOF

#1113
US20210128652A1
Human necessities

AAV TRANSFER CASSETTE

#1114 ✅ Patent 11,951,141 granted on 2024-04-09
US20210128653A1
Human necessities

Replication-enhanced oncolytic adenoviruses

#1115
US20210128654A1
Human necessities

COMPOSITION FOR TREATING, PREVENTING, OR IMPROVING MALE INFERTILITY

#1116 ✅ Patent 11,857,587 granted on 2024-01-02
US20210128655A1
Human necessities

Bioactive extract

#1117
US20210128656A1
Human necessities

COMPOSITION CONTAINING PORIA COCOS PEEL EXTRACT FOR TREATING NEURODEGENERATIVE DISORDERS

#1118
US20210128657A1
Human necessities

EXTRACTION OF PHARMACEUTICALLY ACTIVE COMPONENTS FROM PLANT MATERIALS

#1119 ✅ Patent 11,607,436 granted on 2023-03-21
US20210128658A1
Human necessities

High yield extraction method for and products of Kanna plants

#1120 ✅ Patent 11,723,938 granted on 2023-08-15
US20210128659A1
Human necessities

Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease

#1121 ✅ Patent 11,219,653 granted on 2022-01-11
US20210128660A1
Human necessities

Composition for enhancing immunity, containing ginseng berry polysaccharides

#1122 ✅ Patent 12,059,445 granted on 2024-08-13
US20210128661A1
Human necessities

Methods for preparing anti-inflammatory herbal extracts comprising and

#1123 ✅ Patent 11,717,551 granted on 2023-08-08
US20210128662A1
Human necessities

Compositions and methods related to (GESHO) extract for the inhibition of polymicrobial biofilm formation

#1124 ✅ Patent 12,070,480 granted on 2024-08-27
US20210128663A1
Human necessities

Compositions and methods to improve exercise performance and recovery

#1125
US20210128664A1
Human necessities

Agent for Activating Astrocyte Glucose Metabolism

#1126
US20210128665A1
Human necessities

COMPOSITIONS AND METHODS TO INHIBIT KIDNEY STONE GROWTH

#1127 ✅ Patent 11,666,622 granted on 2023-06-06
US20210128666A1
Human necessities

Topical treatment for animals

#1128
US20210128667A1
Human necessities

IMMUNOPROTEASOME INHIBITORS AND IMMUNOSUPPRESSIVE AGENT IN THE TREATMENT OF AUTOIMMUNE DISORDERS

#1129 ✅ Patent 11,666,623 granted on 2023-06-06
US20210128668A1
Human necessities

Tetramaleimide linkers and use thereof

#1130 ✅ Patent 11,364,275 granted on 2022-06-21
US20210128669A1
Human necessities

Linear lipopeptide paenipeptins and methods of using the same

#1131 ✅ Patent 11,654,196 granted on 2023-05-23
US20210128670A1
Human necessities

Dosing regimens for echinocandin class compounds

#1132 ✅ Patent 11,464,825 granted on 2022-10-11
US20210128671A1
Human necessities

Adiponectin peptidomimetics for treating ocular disorders

#1133 ✅ Patent 11,672,842 granted on 2023-06-13
US20210128672A1
Human necessities

Gonadotropin-releasing hormones for use as adjuvant immunotherapeutics

#1134 ✅ Patent 11,766,468 granted on 2023-09-26
US20210128673A1
Human necessities

Method of treating prostate cancer with GnRH antagonist

#1135
US20210128674A1
Human necessities

LHRH-CONJUGATED PRODIGIOSIN AND USES THEREOF

#1136
US20210128675A1
Human necessities

LHRH-PACLITAXEL CONJUGATES AND METHODS OF USE

#1137
US20210128676A1
Human necessities

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 AND LOW MEAN ARTERIAL PRESSURE

#1138 ✅ Patent 11,524,045 granted on 2022-12-13
US20210128677A1
Human necessities

Peptides for dry eye disease

#1139 ✅ Patent 11,382,948 granted on 2022-07-12
US20210128678A1
Human necessities

Association of N-acetylcysteine and colistin for use in bacterial infections

#1140 ✅ Patent 11,883,459 granted on 2024-01-30
US20210128679A1
Human necessities

Thiol isomerases inhibitors for the treatment and prevention of food allergies, allergic diseases, and inflammatory diseases

#1141
US20210128680A1
Human necessities

METHOD FOR TREATING CARDIOPULMONARY DISORDER

#1142 ✅ Patent 12,311,009 granted on 2025-05-27
US20210128681A1
Human necessities

Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein

#1143 ✅ Patent 11,524,049 granted on 2022-12-13
US20210128682A1
Human necessities

Formulations and methods of use for alpha connexin c-terminal (ACT) peptides

#1144
US20210128683A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR RELIEVING RESISTANCE DUE TO CANCER CHEMOTHERAPY AND ENHANCING EFFECT OF CANCER CHEMOTHERAPY

#1145 ✅ Patent 12,263,204 granted on 2025-04-01
US20210128684A1
Human necessities

Anti-tumor therapeutic agents based on B7h receptor ligands

#1146
US20210128685A1
Human necessities

PEDF-DERIVED PEPTIDES FOR PROMOTING MEIBOMIAN GLAND REGENERATION AND USES THEREOF

#1147 ✅ Patent 11,517,610 granted on 2022-12-06
US20210128686A1
Human necessities

Bone repair material and preparation method thereof, and biological composite scaffold

#1148
US20210128687A1
Human necessities

METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS

#1149 ✅ Patent 11,766,469 granted on 2023-09-26
US20210128688A1
Human necessities

Q-peptide hydrogel promotes immune modulation and macrophage differentiation

#1150
US20210128689A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING ALLERGIC DISORDERS

#1151
US20210128690A1
Human necessities

METHODS OF ADMINISTERING HEPCIDIN

#1152
US20210128691A1
Human necessities

EXTENDED RELEASE L-TRI-IODOTHYRONINE AMELIORATES THE PATHOPHYSIOLOGY OF THE MATERNAL PRE-ECLAMPSIA SYNDROME

#1153
US20210128692A1
Human necessities

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

#1154 ✅ Patent 11,439,687 granted on 2022-09-13
US20210128693A1
Human necessities

Blood plasma fractions for use in muscle regeneration

#1155
US20210128694A1
Human necessities

METHODS AND COMPOSITIONS FOR PREVENTING OR MINIMIZING EPITHELIAL-MESENCHYMAL TRANSITION

#1156 ✅ Patent 12,083,167 granted on 2024-09-10
US20210128695A1
Human necessities

Ovotransferrin treatment for the reproductive tract

#1157
US20210128696A1
Human necessities

BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA

#1158 ✅ Patent 11,865,164 granted on 2024-01-09
US20210128697A1
Human necessities

Pharmaceutical composition for treating cancer, containing guide RNA and endonuclease as active ingredients

#1159
US20210128698A1
Human necessities

CHITINASE ADMINISTRATION TO THE AIRWAY TO TREAT INFLAMMATION AND AGE-RELATED PULMONARY FIBROSIS

#1160
US20210128699A1
Human necessities

NEUTROPHIL ACTIVATION REGULATOR

#1161
US20210128700A1
Human necessities

VIRAL VECTORS ENCODING RECOMBINANT FIX WITH INCREASED EXPRESSION FOR GENE THERAPY OF HEMOPHILIA B

#1162
US20210128701A1
Human necessities

COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION

#1163
US20210128702A1
Human necessities

USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS

#1164
US20210128703A1
Human necessities

Compositions Of Engineered Human Arginases And Methods For Treating Cancer

#1165 ✅ Patent 11,911,450 granted on 2024-02-27
US20210128704A1
Human necessities

Method for managing pain

#1166 ✅ Patent 12,036,270 granted on 2024-07-16
US20210128705A1
Human necessities

Method for immunomodulation of using aza-podophyllotoxin derivatives

#1167
US20210128706A1
Human necessities

VACCINE COMPOSITION

#1168 ✅ Patent 11,058,755 granted on 2021-07-13
US20210128707A1
Human necessities

A*03 restricted peptides for use in immunotherapy against cancers and related methods

#1169 ✅ Patent 11,872,270 granted on 2024-01-16
US20210128708A1
Human necessities

A*03 restricted peptides for use in immunotherapy against cancers and related methods

#1170
US20210128709A1
Human necessities

COMBINATORIAL ANDROGEN DEPRIVATION WITH AN ANDROGEN RECEPTOR VACCINE

#1171
US20210128710A1
Human necessities

COMBINATION THERAPY TO TREAT BRAIN CANCER

#1172 ✅ Patent 11,351,238 granted on 2022-06-07
US20210128711A1
Human necessities

Vaccines against malaria transmission

#1173 ✅ Patent 11,701,419 granted on 2023-07-18
US20210128712A1
Human necessities

Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof

#1174 ✅ Patent 12,042,533 granted on 2024-07-23
US20210128713A1
Human necessities

Irradiation-inactivated poliovirus, compositions including the same, and methods of preparation

#1175 ✅ Patent 11,759,512 granted on 2023-09-19
US20210128714A1
Human necessities

Modified norovirus VP1 proteins and VLPs comprising modified norovirus VP1 proteins

#1176 ✅ Patent 11,576,964 granted on 2023-02-14
US20210128715A1
Human necessities

Methods of generating broadly protective vaccine compositions comprising hemagglutinin

#1177 ✅ Patent 12,201,680 granted on 2025-01-21
US20210128716A1
Human necessities

Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen

#1178
US20210128717A1
Human necessities

VACCINE COMPOSITION

#1179 ✅ Patent 11,771,760 granted on 2023-10-03
US20210128718A1
Human necessities

Treatment and prevention of house dust mite allergies

#1180
US20210128719A1
Human necessities

MODULAR ANTIGEN TRANSPORTATION MOLECULES AND USES THEREOF IN ANIMALS

#1181 ✅ Patent 11,305,010 granted on 2022-04-19
US20210128720A1
Human necessities

Synthetic opioid vaccine

#1182
US20210128721A1
Human necessities

IMMUNOMODULATORY THERAPEUTIC MRNA COMPOSITIONS ENCODING ACTIVATING ONCOGENE MUTATION PEPTIDES

#1183 ✅ Patent 12,048,744 granted on 2024-07-30
US20210128722A1
Human necessities

RANKL-specific agent for treating metastatic disease

#1184 ✅ Patent 11,690,911 granted on 2023-07-04
US20210128723A1
Human necessities

Combination of ATR kinase inhibitors and PD-1/PD-L1 inhibitors

#1185
US20210128724A1
Human necessities

CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT OF CORTICAL SPREADING DEPRESSION ASSOCIATED DISORDERS

#1186
US20210128725A1
Human necessities

CYTOTOXIC LIPID PARTICLES TARGETED TO TUMOR-ASSOCIATED MYELOID CELLS (TAMCS) AND SYNERGIZED WITH RADIATION THERAPY FOR TREATING GLIOBLASTOMA

#1187
US20210128726A1
Human necessities

METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS

#1188
US20210128727A1
Human necessities

A pharmaceutical combination for use in the treatment of cancer

#1189
US20210128728A1
Human necessities

PROLACTIN RECEPTOR ANTIBODY FOR MALE AND FEMALE PATTERN HAIR LOSS

#1190
US20210128729A1
Human necessities

STABLE AQUEOUS ANTIBODY FORMULATION

#1191
US20210128730A1
Human necessities

METHODS FOR TREATING TUMORS

#1192
US20210128731A1
Human necessities

NANOPARTICLES FOR BORON NEUTRON CAPTURE THERAPY AND FOR DIAGNOSING, DETECTING, AND TREATING CANCER

#1193 ✅ Patent 11,478,549 granted on 2022-10-25
US20210128732A1
Human necessities

Compositions and methods for treatment of pre-cancerous skin lesions

#1194 ✅ Patent 11,253,600 granted on 2022-02-22
US20210128733A1
Human necessities

Bioorthogonal compositions

#1195 ✅ Patent 12,257,308 granted on 2025-03-25
US20210128734A1
Human necessities

Stimuli-responsive PEG-like polymer-based drug delivery platform

#1196
US20210128735A1
Human necessities

BIOCOMPATIBLE COPOLYMER CONTAINING MULTIPLE ACTIVE AGENT MOLECULES

#1197
US20210128736A1
Human necessities

STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY

#1198 ✅ Patent 11,744,898 granted on 2023-09-05
US20210128737A1
Human necessities

Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

#1199 ✅ Patent 11,850,285 granted on 2023-12-26
US20210128738A1
Human necessities

Insulin-responsive glucagon delivery patch

#1200 ✅ Patent 11,931,419 granted on 2024-03-19
US20210128739A1
Human necessities

Programmable polymeric drugs